Confidential Materials omitted and filed separately with the Securites and Exchange Commission. Asterisks denote omissions. BT VACCINE LICENSE AGREEMENTVaccine License Agreement • August 14th, 2006 • Emergent BioSolutions Inc. • New York
Contract Type FiledAugust 14th, 2006 Company JurisdictionTHIS BT VACCINE LICENSE AGREEMENT (this “Agreement”), effective as of November 23, 2004, (the “Effective Date”), by and between Emergent BioSolutions, Inc., a corporation organized and existing under the laws of the State of Delaware (“Emergent”), and the Health Protection Agency, a governmental agency organized and existing under the laws of England (“HPA”) (each of Emergent and HPA, a “Party”).